SAN DIEGO--(BUSINESS WIRE)--Sevion Therapeutics, Inc. ("Sevion" or the "Company") (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today reported financial results for the fiscal year ended June 30, 2015 (“Fiscal 2015”) and also provided an overview of corporate accomplishments and plans.
Fiscal Fourth Quarter 2015 and Recent Highlights
Help employers find you! Check out all the jobs and post your resume.
Fiscal Fourth Quarter 2015 and Recent Highlights
Help employers find you! Check out all the jobs and post your resume.
